🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study consists of a Phase 1b portion aimed to determine the maximum to...
Status
Terminated
Location
Anschutz Inpatient Pavilion
Start Date
2014-09-03
Trial ID
NCT02109445
This study is being conducted to characterize the efficacy and safety of ni...
Status
Active Not Recruiting
Location
Nagoya University Hospital
Start Date
2025-08-08
Trial ID
NCT07170644
Treatments Being Tested
This study will evaluate the effects of nirogacestat 100 mg twice daily (BI...
Status
Completed
Location
ICON Martini Groningen CRU
Start Date
2025-10-27
Trial ID
NCT07259330
Treatments Being Tested
This program is being offered on a patient by patient basis and will requir...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05041036
Treatments Being Tested
Multiple myeloma (MM) is a plasma cell disease characterized by the growth ...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences /ID# 243096
Start Date
2022-10-20
Trial ID
NCT05259839
Treatments Being Tested
The purpose of this study is to determine the recommended Phase 2 dose for ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02462707
Treatments Being Tested
This study is being conducted to study how nirogacestat may affect the ovar...
Status
Recruiting
Location
Cliniques Universitaires Saint-Luc (CUSL)
Start Date
2025-09-17
Trial ID
NCT07176689
Treatments Being Tested
This phase 2 clinical trial will study the effectiveness of nirogacestat in...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center
Start Date
2022-08-30
Trial ID
NCT05348356
Treatments Being Tested
This study evaluates nirogacestat (PF-03084014) in the treatment of desmoid...
Status
Completed
Location
Arkansas Children's Hospital
Start Date
2019-04-17
Trial ID
NCT03785964
Treatments Being Tested
This study will evaluate the effects of the H2 blocker famotidine or the PP...
Status
Completed
Location
Medpace
Start Date
2025-08-21
Trial ID
NCT07171619
Treatments Being Tested